verapamil and dofequidar

verapamil has been researched along with dofequidar in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuruo, T2
Ford, PJ; Germann, UA; Harding, MW; Mason, VS; Shlyakhter, D1
Hanibuchi, M; Parajuli, P; Shrivastava, P; Sone, S; Tsuruo, T; Yano, S1
Augustine, AM; Baranowska-Kortylewicz, J; Kortylewicz, ZP; McGarry, J; Nearman, J1

Reviews

2 review(s) available for verapamil and dofequidar

ArticleYear
[Development of drugs to overcome drug resistance--basic approaches].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Humans; Leukemia P388; Leukemia, Myeloid; Mice; Mice, Nude; Quinolines; Tumor Cells, Cultured; Verapamil

1995
[MDR reversing drugs for clinical development].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Animals; Antineoplastic Agents; Cyclosporins; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Leukemia P388; Mice; Quinolines; Verapamil

1994

Other Studies

3 other study(ies) available for verapamil and dofequidar

ArticleYear
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Anti-cancer drugs, 1997, Volume: 8, Issue:2

    Topics: Acridines; Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; HL-60 Cells; Humans; Isoquinolines; Multidrug Resistance-Associated Proteins; Piperidines; Pyridines; Quinolines; Tetrahydroisoquinolines; Tritium; Verapamil; Vincristine

1997
Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Quinolines; Tumor Cells, Cultured; Verapamil

1998
Radioiodinated agents for imaging multidrug resistant tumors.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2009, Volume: 5, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; Iodine Radioisotopes; Mice; Mice, Nude; Molecular Structure; Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Verapamil

2009